Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 32451-32500 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT06892015
OBSERVATIONAL STUDY ON VIRAL SHEDDING AND IMMUNOLOGICAL RESPONSE OF OROPOUCHE VIRUS
N/ARecruiting
30 participants
Started: Dec 19, 2024 · Completed: Oct 31, 2026
1 condition1 sponsor1 location
NCT06269679
CBCT vs OPT on the Oral Health Status at 12 Months of Patients Hospitalized for Infective Endocarditis.
NARecruiting
170 participants
Started: Dec 18, 2024 · Completed: Jul 18, 2028
1 condition1 sponsor10 locations
NCT06334952
Efficacy of Personnalized Transcranial Direct Current Electrical Stimulation (tDCS) in Drug-resistant Epileptic
NARecruiting
60 participants
Started: Dec 18, 2024 · Completed: Nov 18, 2027
2 conditions4 sponsors7 locations
NCT06656494
ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies
PHASE1Recruiting
206 participants
Started: Dec 18, 2024 · Completed: Jan 31, 2028
2 conditions1 sponsor6 locations
NCT05672836
ENAVOgliflozin Outcome Trial in Patients With Severe Aortic Stenosis After Transcatheter Aortic Valve Replacement
PHASE4Recruiting
1,040 participants
Started: Dec 18, 2024 · Completed: Apr 30, 2027
2 conditions3 sponsors31 locations
NCT06549153
ACT-Together (Acting on Cancer Testing-Together)
NAActive, not recruiting
30 participants
Started: Dec 18, 2024 · Completed: Dec 1, 2027
1 condition1 sponsor1 location
NCT06736041
Study of a 4-Dose Regimen of a 21-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age
PHASE3Recruiting
1,630 participants
Started: Dec 18, 2024 · Completed: May 17, 2027
1 condition1 sponsor86 locations
NCT06719050
Telehealth-Based Chronic Disease Management for Type 2 Diabetes
N/ANot yet recruiting
1,636 participants
Started: Dec 18, 2024 · Completed: Dec 31, 2027
1 condition1 sponsor0 locations
NCT06514261
Testing the Combination of an Anti-Cancer Drug, Iadademstat, With Other Anti-Cancer Drugs (Venetoclax and Azacitidine) for Treating AML
PHASE1Recruiting
45 participants
Started: Dec 18, 2024 · Completed: Sep 16, 2026
1 condition1 sponsor4 locations
NCT06423573
A Study to Assess the Incidence of Skin Cancers in Patients With Epidermolysis Bullosa Receiving Filsuvez
N/ARecruiting
580 participants
Started: Dec 18, 2024 · Completed: Aug 1, 2032
2 conditions2 sponsors5 locations
NCT06695026
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 in Combination With Valganciclovir (VGCV) and Atezolizumab/Bevacizumab in Subjects With Hepatocellular Carcinoma
PHASE1/PHASE2Recruiting
45 participants
Started: Dec 18, 2024 · Completed: Oct 31, 2027
1 condition1 sponsor9 locations
NCT06693687
A Study of the ApricityCare Program for Early Detection and Management of Treatment-Related Adverse Events in Patients With Cancer
NARecruiting
425 participants
Started: Dec 18, 2024 · Completed: Nov 1, 2027
1 condition1 sponsor1 location
NCT06694259
Comparison of Anatomical and Functional Outcomes of Laser Photocoagulation and Cryopexy in Patients with Rhegmatogenous Retinal Detachment Treated with Pneumatic Retinopexy
NARecruiting
40 participants
Started: Dec 18, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT07002411
Hospitality Oriented Service Perception Evolution With Robots (HOSPER)
NARecruiting
200 participants
Started: Dec 18, 2024 · Completed: Jul 30, 2025
2 conditions1 sponsor1 location
NCT06469788
Testimonials and Navigation in Rheumatology
NARecruiting
1,170 participants
Started: Dec 18, 2024 · Completed: Aug 31, 2027
2 conditions3 sponsors3 locations
NCT06402851
Vitamin K AntagonISt, Factor Xa Inhibitor or No Anticoagulation in Atrial Fibrillation and DIalytic End-stage Renal DiseasE (VISIONAIRE)
PHASE4Recruiting
1,500 participants
Started: Dec 18, 2024 · Completed: Dec 31, 2026
2 conditions2 sponsors6 locations
NCT06713499
A Phase Ib/II Study to Investigate the Safety of SHR-1819 in Children and Adolescents With Moderate-to-severe Atopic Dermatitis
PHASE1/PHASE2Recruiting
50 participants
Started: Dec 18, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06655415
Family Members At INcreased-risk for Developing Inflammatory Bowel Disease
N/ARecruiting
50 participants
Started: Dec 18, 2024 · Completed: Dec 31, 2034
13 conditions1 sponsor1 location
NCT06480786
SCS for Patient With Painful Diabetic Neuropathy and Peripheral Arterial Disease
NARecruiting
15 participants
Started: Dec 18, 2024 · Completed: Jul 31, 2027
7 conditions2 sponsors1 location
NCT06696443
Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN)
PHASE3Enrolling by invitation
300 participants
Started: Dec 18, 2024 · Completed: Jan 25, 2027
1 condition1 sponsor64 locations
NCT06701721
A Study Intravitreal THN391 in Diabetic Macular Oedema Secondary to Non-Proliferative Diabetic Retinopathy.
PHASE1Recruiting
21 participants
Started: Dec 18, 2024 · Completed: Feb 28, 2026
2 conditions1 sponsor2 locations
NCT06817577
NG004 in Spinal Cord Injury Patients
PHASE1Recruiting
21 participants
Started: Dec 18, 2024 · Completed: Sep 30, 2026
7 conditions1 sponsor6 locations
NCT06286800
Personalized Transcranial Direct Current Stimulation in Stroke Recovery
NARecruiting
80 participants
Started: Dec 18, 2024 · Completed: Sep 14, 2026
1 condition1 sponsor1 location
NCT06711705
Elranatamab in Relapsed/Refractory Multiple Myeloma
PHASE2Recruiting
33 participants
Started: Dec 18, 2024 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT06736834
Sensory Evaluation of Chinese Specialty Foods
NANot yet recruiting
120 participants
Started: Dec 18, 2024 · Completed: Dec 30, 2024
3 conditions1 sponsor0 locations
NCT06710028
Trustworthy Artificial Intelligence for Improvement of Stroke Outcomes
N/ARecruiting
1,000 participants
Started: Dec 18, 2024 · Completed: Dec 31, 2026
3 conditions1 sponsor3 locations
NCT06743789
Trial in Arrhythmia Radioablation for Ventricular Tachycardia: Single Fraction vs Three Fractions
NARecruiting
40 participants
Started: Dec 18, 2024 · Completed: Dec 31, 2030
1 condition1 sponsor1 location
NCT06777849
Mainstreaming a Life Skills Education Programme Right to Play- Plus to Reduce Violence Against Girls in Pakistan
NARecruiting
3,000 participants
Started: Dec 18, 2024 · Completed: May 31, 2027
5 conditions2 sponsors2 locations
NCT06750978
Interventions for PSU Among College Students
NAEnrolling by invitation
48 participants
Started: Dec 18, 2024 · Completed: Apr 30, 2025
1 condition1 sponsor1 location
NCT06894121
Comparing Unilateral and Bilateral Proximal GONPRF in Migraine Treatment
NARecruiting
190 participants
Started: Dec 18, 2024 · Completed: Jan 31, 2026
3 conditions1 sponsor2 locations
NCT06618755
Motivational Interviews Post Hospitalisation on Maintaining AbstiNence for 1 Year après le Sevrage en Alcool
NARecruiting
104 participants
Started: Dec 18, 2024 · Completed: Sep 1, 2026
5 conditions1 sponsor1 location
NCT06508450
A Mental Health Services Engagement Program for Racial and Ethnic Minority Young Adults
NARecruiting
80 participants
Started: Dec 18, 2024 · Completed: Mar 31, 2027
3 conditions1 sponsor1 location
NCT06810050
Phase 2b Safety and Efficacy Study of CGB-500 Topical Ointment with 0.5% and 1% Tofacitnib for Treatment of Atopic Dermatitis
PHASE2Recruiting
180 participants
Started: Dec 18, 2024 · Completed: Oct 30, 2025
1 condition1 sponsor16 locations
NCT05981300
GpCRC Pediatric Gastroparesis Registry 2
N/ARecruiting
216 participants
Started: Dec 18, 2024 · Completed: Jun 30, 2027
2 conditions8 sponsors6 locations
NCT06701526
A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications
PHASE4Recruiting
150 participants
Started: Dec 18, 2024 · Completed: Jun 5, 2026
1 condition1 sponsor22 locations
NCT06742190
A Study to Assess the Efficacy and Safety of Empasiprubart Versus IVIg in Adults With Multifocal Motor Neuropathy
PHASE3Recruiting
115 participants
Started: Dec 18, 2024 · Completed: Dec 31, 2029
2 conditions1 sponsor55 locations
NCT06269640
NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Early Feasibility Study
NARecruiting
30 participants
Started: Dec 18, 2024 · Completed: Oct 1, 2027
4 conditions1 sponsor2 locations
NCT07007910
Phase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate Cancer
PHASE1Recruiting
90 participants
Started: Dec 18, 2024 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT06670755
ID93/GLA-SE Vaccination + BCG Challenge
NARecruiting
48 participants
Started: Dec 18, 2024 · Completed: Jul 31, 2027
1 condition1 sponsor1 location
NCT06713239
A Randomized Comparison of Personalized Therapy Mgmt Based On Coronary Atherosclerotic Plaque Vs. Usual Care for Symptomatic Patients With Suspicion of CAD
NARecruiting
1,000 participants
Started: Dec 18, 2024 · Completed: Dec 31, 2025
1 condition1 sponsor21 locations
NCT06753331
A Multicenter Study to Evaluate Safety, Tolerability, and Clinical Responses of DSP-1083 Into Subjects With Parkinson's Disease
PHASE1Recruiting
23 participants
Started: Dec 18, 2024 · Completed: Mar 1, 2029
1 condition1 sponsor2 locations
NCT06803446
Effects of Circadian Rhythm on Glycemic Regulation During Continuous Moderate Exercise and Intense Intermittent Disease in Adolescents Living With Type 1 Diabetes
NARecruiting
18 participants
Started: Dec 18, 2024 · Completed: Dec 19, 2026
1 condition1 sponsor1 location
NCT06657326
LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients
NARecruiting
444 participants
Started: Dec 18, 2024 · Completed: Dec 31, 2030
5 conditions1 sponsor6 locations
NCT05904093
Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
PHASE1Recruiting
25 participants
Started: Dec 18, 2024 · Completed: May 14, 2026
6 conditions1 sponsor1 location
NCT07164339
Intraoperative Perfusion Index and Mortality
N/AActive, not recruiting
425,000 participants
Started: Dec 18, 2024 · Completed: Oct 31, 2025
3 conditions1 sponsor1 location
NCT06540079
BIOTRONIK Conduction System Pacing With the Solia Lead - Solia CSP S
NARecruiting
220 participants
Started: Dec 18, 2024 · Completed: Jun 30, 2026
3 conditions1 sponsor10 locations
NCT06799260
Motor Cortex Plasticity Response to Theta-Burst Stimulation After Ketone Monoester Supplementation
NAActive, not recruiting
40 participants
Started: Dec 18, 2024 · Completed: Dec 1, 2025
2 conditions2 sponsors1 location
NCT06884943
Generalization With AI Navigation Using StaRt
PHASE2Recruiting
76 participants
Started: Dec 18, 2024 · Completed: Jul 1, 2029
1 condition3 sponsors2 locations
NCT06241430
The CardioClip Study
NARecruiting
60 participants
Started: Dec 18, 2024 · Completed: Nov 30, 2027
2 conditions2 sponsors1 location
NCT06020495
Systematic Use of DDAVP to Prevent Serum Sodium Overcorrection in Severe Hyponatremia
PHASE3Recruiting
260 participants
Started: Dec 17, 2024 · Completed: Nov 30, 2026
1 condition1 sponsor12 locations